Skip to main content
Top

16-12-2017 | Supportive care | Article

Genetics in palliative oncology: a missing agenda? A review of the literature and future directions

Journal: Supportive Care in Cancer

Authors: April Morrow, Chris Jacobs, Megan Best, Sian Greening, Kathy Tucker

Publisher: Springer Berlin Heidelberg

Abstract

Purpose

In the palliative oncology setting, genetic assessment may not impact on the patient’s management but can be of vital importance to their surviving relatives. Despite care of the family being central to the ethos of palliative care, little is known about how hereditary aspects of cancer are addressed in this setting. This review aims to examine current practices, identify practice barriers and determine the genetic information and support needs of patients, family members and health providers.

Methods

Key databases were systematically searched to identify both quantitative and qualitative studies that addressed these aims. Data was extracted and coded using thematic analysis.

Results

Eight studies were included for review. Suboptimal genetic practices were identified, with lack of knowledge and poor confidence amongst providers reported as barriers in both qualitative and quantitative studies. Providers expressed concern about the emotional impact of initiating these discussions late in the disease trajectory; however, qualitative interviews amongst palliative patients suggested there may be emotional benefits.

Conclusions

All lines of evidence suggest that genetics is currently missing from the palliative agenda, signifying lost opportunities for mutation detection, genetic counselling and appropriate risk management for surviving relatives. There is an urgent need for interventions to improve provider knowledge and awareness of genetic referral pathways and for research into the genetic information and support needs of palliative care patients.
Literature
1.
Addington-Hall J (2002) Research sensitivities to palliative care patients. Eur J Cancer Care 11(3):220–224. https://​doi.​org/​10.​1046/​j.​1365-2354.​2002.​00343.​x CrossRef
2.
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70(23):9742–9754. https://​doi.​org/​10.​1158/​0008-5472.​CAN-10-1907 CrossRefPubMedPubMedCentral
3.
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101. https://​doi.​org/​10.​1191/​1478088706qp063o​a CrossRef
4.
Burke S, Kirk M (2006) Genetics education in the nursing profession: literature review. J Adv Nurs 54(2):228–237. https://​doi.​org/​10.​1111/​j.​1365-2648.​2006.​03805.​x CrossRefPubMed
5.
Casarett DJ, Karlawish JH (2000) Are special ethical guidelines needed for palliative care research? J Pain Symptom Manag 20(2):130–139. https://​doi.​org/​10.​1016/​S0885-3924(00)00164-0 CrossRef
6.
Cohen PA, Nichols CB, Schofield L, Van Der Werf S, Pachter N (2016) Impact of clinical genetics attendance at a gynecologic oncology tumor board on referrals for genetic counseling and BRCA mutation testing. Int J Gynecol Cancer 26(5):892–897. https://​doi.​org/​10.​1097/​IGC.​0000000000000689​ CrossRefPubMed
7.
Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C (2014) Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Cancer Netw 12(9):1326–1338. https://​doi.​org/​10.​6004/​jnccn.​2014.​0127 CrossRef
8.
Daniels MS, Urbauer DL, Stanley JL, Johnson KG, KH L (2009) Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer. Genetics Med 11(9):624–628. https://​doi.​org/​10.​1097/​GIM.​0b013e3181ab2295​ CrossRef
9.
Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975. https://​doi.​org/​10.​1001/​jama.​2010.​1237 CrossRefPubMedPubMedCentral
10.
Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Kossler T, Pharoah P, Schafmayer C, Hampe J, Völzke H (2012) Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals Gut: gutjnl-2011-300537
11.
Feuz C (2014) Shared decision making in palliative cancer care: a literature review. J Radiother Pract 13(03):340–349. https://​doi.​org/​10.​1017/​S146039691300046​0 CrossRef
12.
Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32(15):1547–1553. https://​doi.​org/​10.​1200/​JCO.​2013.​53.​2820 CrossRefPubMedPubMedCentral
13.
Gaff CL (2005) Identifying clients who might benefit from genetic services and information. Nurs Stand 20(1):49–53. https://​doi.​org/​10.​7748/​ns.​20.​1.​49.​s56 CrossRefPubMed
14.
Garber JE, Offit K (2005) Hereditary cancer predisposition syndromes. J Clin Oncol 23(2):276–292. https://​doi.​org/​10.​1200/​JCO.​2005.​10.​042 CrossRefPubMed
15.
Gardner DS, Kramer BJ (2010) End-of-life concerns and care preferences: congruence among terminally ill elders and their family caregivers. OMEGA-J Death and Dying 60(3):273–297. https://​doi.​org/​10.​2190/​OM.​60.​3.​e CrossRef
16.
Hallowell N (1999) Doing the right thing: genetic risk and responsibility. Sociol Health Illness 21:597–621CrossRef
17.
Hirschberg AM, Chan-Smutko G, Pirl WF (2015) Psychiatric implications of cancer genetic testing. Cancer 121(3):341–360. https://​doi.​org/​10.​1002/​cncr.​28879 CrossRefPubMed
18.
Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A (1998) Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology 7(5):402–412. https://​doi.​org/​10.​1002/​(SICI)1099-1611(1998090)7:​5<402:​:​AID-PON317>3.​0.​CO;2-X CrossRefPubMed
19.
Ingleby LJ (2015) Clinical genetics in a palliative care setting: a qualitative exploration of the barriers and levers staff report when discussing family risk of BRCA 1 and BRCA 2 mutations. In: Editor (ed)^(eds) book clinical genetics in a palliative care setting: a qualitative exploration of the barriers and levers staff report when discussing family risk of BRCA 1 and BRCA 2 mutations. School of Psychology, City
20.
Kentwell M, Dow E, Antill Y, Wrede CD, McNally O, Higgs E, Hamilton A, Ananda S, Lindeman GJ, Scott CL (2017) Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecol Oncol 145(1):130–136. https://​doi.​org/​10.​1016/​j.​ygyno.​2017.​01.​030 CrossRefPubMed
21.
Kirk J (2004) The family history of cancer—a common concern in palliative care. Progress Palliat Care 12(2):59–66. https://​doi.​org/​10.​1179/​0969926042250052​63 CrossRef
22.
Kirk M, McDonald K, Anstey S, Longley M (2003) Fit for practice in the genetics era: a competence based education framework for nurses, midwives and health visitors University of Glamorgan, Pontypridd: 72
23.
Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. In: editor (ed)^(eds) book standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research Edmonton, City
24.
Leighl NB, Butow PN, Tattersall MH (2004) Treatment decision aids in advanced cancer: when the goal is not cure and the answer is not clear. J Clin Oncol 22(9):1759–1762. https://​doi.​org/​10.​1200/​JCO.​2004.​02.​166 CrossRefPubMed
25.
Lillie AK (2009) ‘The missing discourse’: how does the family history of cancer affect the care needs of palliative care patients? In: editor (ed)^(eds) book ‘the missing discourse’: how does the family history of cancer affect the care needs of palliative care patients? University of Birmingham, City
26.
Lillie AK, Clifford C, Metcalfe A (2011) Caring for families with a family history of cancer: why concerns about genetic predisposition are missing from the palliative agenda. Palliat Med 25(2):117–124. https://​doi.​org/​10.​1177/​0269216310383738​ CrossRefPubMed
27.
Maradiegue A, Edwards QT, Seibert D, Macri C, Sitzer L (2005) Knowledge, perceptions, and attitudes of advanced practice nursing students regarding medical genetics. J Am Acad Nurse Pract 17(11):472–479. https://​doi.​org/​10.​1111/​j.​1745-7599.​2005.​00076.​x CrossRefPubMed
28.
Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 14(12):1060–1074. https://​doi.​org/​10.​1002/​pon.​933 CrossRefPubMed
29.
Metcalfe A, Burton H (2003) Postregistration genetics education provision for nurses, midwives and health visitors in the UK. J Adv Nurs 44(4):350–359. https://​doi.​org/​10.​1046/​j.​0309-2402.​2003.​02814.​x CrossRefPubMed
30.
Metcalfe A, Pumphrey R, Clifford C (2010) Hospice nurses and genetics: implications for end-of-life care. J Clin Nurs 19(1-2):192–207. https://​doi.​org/​10.​1111/​j.​1365-2702.​2009.​02935.​x CrossRefPubMed
31.
Möller S, Mucci LA, Harris JR, Scheike T, Holst K, Halekoh U, Adami H-O, Czene K, Christensen K, Holm NV (2016) The heritability of breast cancer among women in the Nordic Twin Study of Cancer. Cancer Epidemiol Prev Biomarkers 25:145–150CrossRef
32.
Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH (2016) Familial risk and heritability of cancer among twins in Nordic countries. JAMA 315(1):68–76. https://​doi.​org/​10.​1001/​jama.​2015.​17703 CrossRefPubMedPubMedCentral
33.
Nelson HD, Huffman LH, Fu R, Harris EL (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 143(5):362–379. https://​doi.​org/​10.​7326/​0003-4819-143-5-200509060-00012 CrossRefPubMed
34.
Organization WH (2007) Palliative care
35.
Percival N, George A, Gyertson J, Hamill M, Fernandes A, Davies E, Rahman N, Banerjee S (2016) The integration of BRCA testing into oncology clinics. Br J Nurs 25(12):690–694. https://​doi.​org/​10.​12968/​bjon.​2016.​25.​12.​690 CrossRefPubMed
36.
Quillin JM, Bodurtha JN, Siminoff LA, Smith TJ (2010) Exploring hereditary cancer among dying cancer patients—a cross-sectional study of hereditary risk and perceived awareness of DNA testing and banking. J Genet Couns 19(5):497–525. https://​doi.​org/​10.​1007/​s10897-010-9308-y CrossRefPubMedPubMedCentral
37.
Quillin JM, Bodurtha JN, Siminoff LA, Smith TJ (2011) Physicians’ current practices and opportunities for DNA banking of dying patients with cancer. J Oncol Pract 7(3):183–187. https://​doi.​org/​10.​1200/​JOP.​2010.​000190 CrossRefPubMedPubMedCentral
38.
Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI (1997) Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet A 71(3):315–324. https://​doi.​org/​10.​1002/​(SICI)1096-8628(19970822)71:​3<315:​:​AID-AJMG12>3.​0.​CO;2-N CrossRef
39.
Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet SC, Manley S, Culver JO, Acton R, Larsen-Haidle J (2004) Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns 13(2):83–114. https://​doi.​org/​10.​1023/​B:​JOGC.​0000018821.​48330.​77 CrossRefPubMed
40.
Verhaak CM, Kraaimaat FW, Staps A, van Daal WA (2000) Informed consent in palliative radiotherapy: participation of patients and proxies in treatment decisions. Patient Educ Couns 41(1):63–71. https://​doi.​org/​10.​1016/​S0738-3991(00)00116-6 CrossRefPubMed